Alerts will be sent to your verified email
Verify Email
FREDUN
|
Fredun Pharma
|
Gennex Lab
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.53 % | 7.82 % | 29.33 % |
|
5yr average Equity Multiplier
|
3.02 | 1.53 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
1.01 | 0.75 | 1.5 |
|
5yr Avg Net Profit Margin
|
2.89 % | 7.88 % | 11.83 % |
|
Price to Book
|
2.51 | 1.75 | 1.59 |
|
P/E
|
17.45 | 16.94 | 12.55 |
|
5yr Avg Cash Conversion Cycle
|
137.13 Days | 43.23 Days | 133.11 Days |
|
Inventory Days
|
140.46 Days | 49.12 Days | 68.7 Days |
|
Days Receivable
|
52.11 Days | 50.53 Days | 81.67 Days |
|
Days Payable
|
131.93 Days | 75.36 Days | 60.92 Days |
|
5yr Average Interest Coverage Ratio
|
2.31 | 6.21 | 92.41 |
|
5yr Avg ROCE
|
16.75 % | 11.17 % | 40.34 % |
|
5yr Avg Operating Profit Margin
|
8.32 % | 10.47 % | 18.05 % |
|
5 yr average Debt to Equity
|
0.86 | 0.18 | 0.05 |
|
5yr CAGR Net Profit
|
52.4 % | 43.63 % | n/a |
|
5yr Average Return on Assets
|
3.05 % | 5.16 % | 20.09 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
48.93 % | 18.42 % | 65.99 % |
|
Share Pledged by Promoters
|
0.0 | 23.87 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.34 % | -3.63 % | -6.87 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Fredun Pharma
|
Gennex Lab
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|